Quote this publication Share Print

DUROGESIC

-
Opinions on drugs - Posted on Apr 26 2010

Reason for request

Assessment of change of dose permitting use in children aged between 2 and 16.

-


Clinical Benefit

Substantial

The clinical benefit provided by DUROGESIC in children is substantial.


Clinical Added Value

Comments without ASMR value

DUROGESIC has previously been recognised by the Transparency Committee as providing actual benefit in adults, and it provides the same benefit for children over 2.


Contact Us

Évaluation des médicaments
All our publications